• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.

作者信息

Méndez-Sánchez Nahum, Valencia-Rodríguez Alejandro, Qi Xingshun, Yoshida Eric M, Romero-Gómez Manuel, George Jacob, Eslam Mohammed, Abenavoli Ludovico, Xie Weifen, Teschke Rolf, Carrion Andres F, Keaveny Andrew P

机构信息

Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.

Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

出版信息

J Clin Transl Hepatol. 2020 Jun 28;8(2):0024. doi: 10.14218/JCTH.2020.00024. Epub 2020 Apr 11.

DOI:10.14218/JCTH.2020.00024
PMID:32309152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7163687/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c65/7163687/15625e419bb2/JCTH-8-109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c65/7163687/15625e419bb2/JCTH-8-109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c65/7163687/15625e419bb2/JCTH-8-109-g001.jpg

相似文献

1
What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.到目前为止，新冠疫情给了我们哪些教训？从肝病学家的角度探讨这一问题。
J Clin Transl Hepatol. 2020 Jun 28;8(2):0024. doi: 10.14218/JCTH.2020.00024. Epub 2020 Apr 11.
2
Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.肝硬化门静脉血栓形成的抗凝时机：一位美国肝病专家的观点
J Transl Int Med. 2018 Mar 28;6(1):1-5. doi: 10.2478/jtim-2018-0001. eCollection 2018 Mar.
3
Hepatitis C: a hepatologist's approach to an infectious disease.丙型肝炎：肝病专家对一种传染病的诊疗方法
Clin Infect Dis. 2001 Nov 15;33(10):1728-32. doi: 10.1086/323128. Epub 2001 Oct 10.
4
Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.肝硬化患者门静脉血栓形成的治疗时机：一位德国肝病学家的观点
J Transl Int Med. 2018 Mar 28;6(1):11-15. doi: 10.2478/jtim-2018-0003. eCollection 2018 Mar.
5
Current status of interferon therapy for chronic hepatitis C: a hepatologist's perspective.慢性丙型肝炎干扰素治疗的现状：肝病专家的观点
Infect Agents Dis. 1993 Jun;2(3):150-4.
6
Adult living donor liver transplantation: the hepatologist's perspective.成人活体肝移植：肝病学家的观点。
Hepatology. 2001 Jan;33(1):3-9. doi: 10.1053/jhep.2001.21489.
7
Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.类风湿关节炎患者甲氨蝶呤肝毒性的监测：另一位肝病学家的观点。
J Rheumatol. 1997 Aug;24(8):1459-60.
8
A hepatologist's perspective on the management of coagulation disorders before liver transplantation.肝病专家对肝移植前凝血障碍管理的看法。
Liver Transpl Surg. 1997 Nov;3(6):646-52. doi: 10.1002/lt.500030619.
9
Liver imaging. A hepatologist's perspective.肝脏影像学：肝病专家的视角
Clin Liver Dis. 2002 Feb;6(1):297-310, ix. doi: 10.1016/s1089-3261(03)00077-1.
10
Principles on the path to a hepatologist's enlightenment.肝病学家成长之路的原则。
Hepatology. 2015 Jul;62(1):8-12. doi: 10.1002/hep.27733. Epub 2015 Mar 18.

引用本文的文献

1
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series.COVID-19患者的肝损伤与凝血功能障碍：病例系列
Diseases. 2023 Oct 13;11(4):141. doi: 10.3390/diseases11040141.
2
Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis.生物信息学和系统生物学方法揭示新型冠状病毒肺炎与非酒精性肝炎之间的共享基因和分子机制。
Front Mol Biosci. 2023 Jun 19;10:1164220. doi: 10.3389/fmolb.2023.1164220. eCollection 2023.
3
COVID-19: Where We Are and Where We Are Going.

本文引用的文献

1
[Clinical features and outcome of treatment for novel coronavirus pneumonia: a meta-analysis].[新型冠状病毒肺炎的临床特征及治疗结果：一项荟萃分析]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):240-246. doi: 10.3760/cma.j.cn501113-20200224-00067.
2
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].[新型冠状病毒肺炎肝损伤防治专家共识]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.
3
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
新冠疫情：我们所处的位置与前行的方向
Diseases. 2023 Mar 1;11(1):40. doi: 10.3390/diseases11010040.
4
COVID-19 and liver injury in individuals with obesity.肥胖人群中的 COVID-19 与肝损伤。
World J Gastroenterol. 2023 Feb 14;29(6):908-916. doi: 10.3748/wjg.v29.i6.908.
5
Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19.COVID-19危重症患者肝病的预防、诊断评估、管理及预后影响
World J Clin Cases. 2023 Jan 26;11(3):514-527. doi: 10.12998/wjcc.v11.i3.514.
6
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.COVID-19 对代谢相关脂肪性肝病患者的临床影响。
World J Gastroenterol. 2023 Jan 21;29(3):487-502. doi: 10.3748/wjg.v29.i3.487.
7
Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2.新型冠状病毒（SARS-CoV-2）介导的组织特异性代谢调节所涉及的分子和细胞机制
Front Microbiol. 2022 Nov 10;13:1037467. doi: 10.3389/fmicb.2022.1037467. eCollection 2022.
8
COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases-A Concise Review.新型冠状病毒肺炎：胃肠道、肝脏及胰腺疾病的现状——简要综述
Trop Med Infect Dis. 2022 Aug 16;7(8):187. doi: 10.3390/tropicalmed7080187.
9
An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic.加拿大肝脏研究协会关于2019冠状病毒病大流行期间肝病管理的最新情况。
Can Liver J. 2020 Nov 17;3(4):309-321. doi: 10.3138/canlivj-2020-0013. eCollection 2020 Fall.
10
The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis.代谢相关脂肪性肝病与新型冠状病毒肺炎临床结局的关联：一项系统评价和Meta分析
Kans J Med. 2022 Jul 21;15(2):241-246. doi: 10.17161/kjm.vol15.16522. eCollection 2022.
人类白细胞抗原易感性图谱与严重急性呼吸综合征冠状病毒 2。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00510-20.
4
Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.肝移植受者围手术期新型冠状病毒肺炎的表现
Hepatology. 2020 Oct;72(4):1491-1493. doi: 10.1002/hep.31257.
5
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.失代偿期肝硬化患者中新型冠状病毒2型感染的预防
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):528-529. doi: 10.1016/S2468-1253(20)30080-7. Epub 2020 Mar 17.
6
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者：第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
7
Sex difference and smoking predisposition in patients with COVID-19.新型冠状病毒肺炎患者的性别差异与吸烟易感性
Lancet Respir Med. 2020 Apr;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X. Epub 2020 Mar 11.
8
[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].[陕西地区新型冠状病毒肺炎合并肝损伤患者的临床特征及影响因素]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):234-239. doi: 10.3760/cma.j.cn501113-20200226-00070.
9
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
10
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.鉴于过去人类冠状病毒爆发情况洞察2019新型冠状病毒（SARS-CoV-2）
Pathogens. 2020 Mar 4;9(3):186. doi: 10.3390/pathogens9030186.